about
Immune targeting of cancer stem cells in gastrointestinal oncologyUtilization of sentinel lymph node biopsy in patients with ductal carcinoma in situ undergoing mastectomyNegligible effect of perioperative epidural analgesia among patients undergoing elective gastric and pancreatic resections.Survival in 12,653 breast cancer patients with extensive axillary lymph node metastasis in the anthracycline eraRelative value units poorly correlate with measures of surgical effort and complexity.Phase I trial of neoadjuvant conformal radiotherapy plus sorafenib for patients with locally advanced soft tissue sarcoma of the extremity.Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcomaDisparities in the use of radiation therapy in patients with local-regionally advanced breast cancer.Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcomaHospital readmissions: necessary evil or preventable target for quality improvement.Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.Predicting survival for well-differentiated liposarcoma: the importance of tumor location.Perioperative radiotherapy is associated with improved survival among patients with synovial sarcoma: A SEER analysis.Sacramento area breast cancer epidemiology study: use of postmastectomy breast reconstruction along the rural-to-urban continuum.Surgical treatment of colon and rectal cancer.The diagnostic dilemma of follicular variant of papillary thyroid carcinoma.Current perioperative outcomes for patients with disseminated cancerEnhanced targeting of stem-like solid tumor cells with radiation and natural killer cellsSurgery in high-volume hospitals not commission on cancer accreditation leads to increased cancer-specific survival for early-stage lung cancer.Medullary carcinoma of the breast: a population-based perspective.Locally Advanced Spiroadenocarcinoma in the Regional Axilla of a Breast Cancer Patient: Hallmarks of Definitive Diagnosis and Management.Increased Rates of Prolonged Length of Stay, Readmissions, and Discharge to Care Facilities among Postoperative Patients with Disseminated Malignancy: Implications for Clinical PracticeUse of radiotracer for sentinel lymph node mapping in breast cancer optimizes staging independent of site of administration.NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell PhenotypeOlder age impacts radiotherapy-related outcomes in soft tissue sarcoma.Natural killer cell immunotherapy to target stem-like tumor cells.Why do patients with low-grade soft tissue sarcoma die?Text messaging among residents and faculty in a university general surgery residency program: prevalence, purpose, and patient careSurgical management of neurofibromatosis.Outcomes of pancreaticoduodenectomy: where should we focus our efforts on improving outcomes?Preoperative CA 19-9 kinetics as a prognostic variable in radiographically resectable pancreatic adenocarcinoma.Surgical approach for soft tissue sarcoma: standard of care and future approaches.Sarcopenia: Current Concepts and Imaging Implications.Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival.Chemotherapy: Does Neoadjuvant or Adjuvant Therapy Improve Outcomes?Conservative management of desmoid tumors is safe and effective.Urban and non-urban disparities in the use of post-mastectomy radiation for breast cancer.Rural-urban disparities in use of post-lumpectomy radiation.Tumor necrosis factor-alpha damages tumor blood vessel integrity by targeting VE-cadherin.Suppression of beta-catenin by antisense oligomers augments tumor response to isolated limb perfusion in a rodent model of adenomatous polyposis coli-mutant colon cancer.
P50
Q26749015-2582EE42-323D-40B0-AF63-331032AB8EADQ30667656-4EB743CE-F3E9-4C17-A11C-DB6996871625Q34084303-B08F8CF0-1344-4443-B418-4087B2D24D28Q34095577-70080C86-FE21-4F41-8E2C-7107FD883884Q34122801-A664C4DA-71EC-4D54-A151-ED280379C713Q34129496-E4500D10-5DAF-4C75-AAEF-618854747977Q34138698-9F4E4BA4-BB8A-4CEB-BCB6-25E13FC7C036Q34158859-F11CDD71-2B0F-46E4-AB87-49DB877C4746Q34354781-38482E06-467B-4A24-8E0F-4CA23B6A8823Q34441403-CA25ECDD-6D3F-42FC-BCFE-206E2AD79F43Q34557221-5EBC3DB7-9334-40E5-B3BA-04C2029E00FCQ34632354-8A3D914E-622B-4F91-8FD6-B071A0307C3DQ34664193-24FE1291-477F-4A9F-85A0-549D637C693FQ34683842-04337B3D-4666-4A3F-B1E6-7C6C45BCF022Q34989818-5267DEF3-D161-4ACD-B39D-12EAE7D4DF6EQ35605412-6141ACF9-310B-42D6-A62B-DD6010E4D6FCQ35688677-D5E4F102-2A90-4BC8-84FA-BFD571496E20Q36060236-8074D463-2F6C-455B-B33D-94683D6A5294Q36075331-D629CC55-9BD6-4DC9-842D-96AB9779DB3CQ36132942-FCDC890F-AC38-4AFD-96D9-95CE7AA48E82Q36146495-B25549D8-DE80-418E-8581-1800EF9D3A52Q36174232-89756DEC-0073-4FA6-BB57-441767D015C2Q36572047-47908D40-381C-4645-844D-D73C7DC6D843Q36660550-D85605D4-6A8A-4C6F-974C-1250702F27F7Q36680534-ECF92C9C-7705-43C0-AE56-B35B83EB7217Q36810433-90A694F3-9DE1-4A94-9CF3-611CCCBCD523Q37019537-5BB9C912-F150-4C72-BF2A-0022EAA9F89DQ37298207-B086360D-BF5F-46A9-AC6D-B94DC82341C5Q37341143-3FB6BAC3-4F0B-4048-B79C-863ECACBE0CAQ38213545-EF9377FD-C50C-4D8C-B132-D7C1DF9D3D4DQ38261491-442C5035-6A93-4CA5-9E0F-64EA280B0951Q38518010-D7288559-2630-425B-BB98-F6352A3DAB7DQ38535287-C90B90A3-CD55-4EC5-B8B0-E74B245FFA8CQ38854307-5E831652-97BE-4680-AC59-347BB1D65814Q38945568-629D117E-4D14-4F3E-B956-8D75A70F0569Q39398556-714D7326-96F3-4A11-99C2-2A4228859B79Q40002147-456A2011-621F-441E-88E1-AE5347BF8D4EQ40040512-CFB2A440-49E4-4F9C-AAE9-AD998A082982Q40216423-CBAC9F2B-312A-43F5-A01E-0443D3F403F0Q40379781-5F864411-537D-486D-8078-043383354020
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Robert J. Canter
@ast
Robert J. Canter
@en
Robert J. Canter
@es
Robert J. Canter
@sl
type
label
Robert J. Canter
@ast
Robert J. Canter
@en
Robert J. Canter
@es
Robert J. Canter
@sl
prefLabel
Robert J. Canter
@ast
Robert J. Canter
@en
Robert J. Canter
@es
Robert J. Canter
@sl
P106
P1153
7004419343
P21
P2798
P31
P496
0000-0002-3331-5418